Explain the Latest Guidance for Gout Management
You’ll get questions about managing patients with gout...due to updated guidelines.
Chronic gout. Last year, FDA warned about febuxostat increasing CV death compared to allopurinol. Now guidelines are catching up with the evidence.
Consider stopping febuxostat if a patient taking it is admitted with an MI, stroke, or other CV event.